Figure 3From: Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy Waterfall plot showing the changes in CEC counts and tumor response in patients without progressive disease (PD) (those with partial response [PR] or stable disease [SD]) and patients with PD, after 28 ± 7 days of gemcitabine treatment. Back to article page